MedTrace Logo

Endotracheal Tube Placement Using McGrath MAC® Video Laryngoscope Versus Macintosh Laryngoscope

NCT03503279 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-06-01

No results posted yet for this study

Summary

This study aims...

* To assess the difference in intubation difficulty scale (IDS) score following ETT placement using McGrath MAC® video laryngoscope versus conventional intubation with Macintosh laryngoscope for bariatric surgery patients
* To assess the difference in hemodynamic stimulation (airway manipulation) events in both groups
* To assess the overall difference of the duration (seconds) of ETT placement between both groups
* To assess the difference of the duration (seconds) of ETT placement during every attempt (maximum of three attempts) between both groups.
* To assess the difference of STOP BANG score between both groups
* To assess the number of intubation attempts between both groups

Conditions

  • Intubation

Interventions

DEVICE

McGrath MAC® Video Laryngoscope

McGrath MAC® Video Laryngoscope have been developed to secure the airway and improve the management of difficult intubation. McGrath MAC® is a self-contained VL with a single-use blade; its structure is similar to the ML, but without the channel that guides the tube and a mounted LCD screen on the handle that is connected to a miniature camera with a light source at the tip of the blade, allowing the clinicians to directly observe surrounding anatomical airway structures during a tracheal intubation

Sponsors & Collaborators

  • Ohio State University

    lead OTHER

Principal Investigators

  • Sergio Bergese · Ohio State University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2021-02-02
Completion
2021-03-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03503279 on ClinicalTrials.gov